BUDZ · XBRL financial data

Weed financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (BUDZ's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	0	0*	0	0	0	0*	0	0	0	0*	0	0
Cost of revenue	—	year only	0	—	—	year only	0	0	—	year only	0	0
Gross profit	—	year only	0	—	—	year only	0	0	—	year only	0	0
General and administrative	25	127*	137	85	65	64*	383	64	59	622*	68	75
Total operating expenses	239	192*	170	145	93	127*	435	94	67	727*	164	91
Operating income (loss)	(239)	(192)*	(170)	(145)	(93)	(127)*	(435)	(94)	(67)	(727)*	(164)	(91)
Interest expense	15	(0)*	1	1	3	(4)*	6	14	2*	—	—	13
Other income (expense)	973	(203)*	(1)	34	(3)	10*	(6)	(14)	(7)	(23)*	(11)	(13)
Income tax expense (benefit)	—	year only	0	0	0	0*	0	0	0	0*	0	0
Net income (loss)	734	(395)	(171)	(111)	(96)	(133)	(440)	(108)	(74)	(750)*	(175)	(104)
Earnings per share, basic USD per share	0.01	—	—	—	—	—	—	—	—	—	—	—
Earnings per share, diluted USD per share	—	—	(0.00)	(0.00)	(0.00)	—	(0.00)	(0.00)	(0.00)	(0.01)*	(0.00)	(0.00)
Weighted average shares, basic thousands of shares	123,483	124,381*	—	—	—	—	—	—	—	—	—	—
Weighted average shares, diluted thousands of shares	—	—	123,809	126,271	126,680	119,791*	132,855	135,933	135,933	138,895*	147,511	148,313

Fiscal quarters (BUDZ's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	644	290	103	15	5	159	3	5	0	33	2	1
Total current assets	684	320	129	37	39	190	36	18	11	48	12	8
Property and equipment, net	520	516	511	506	501	496	491	486	481	476	471	467
Right-of-use asset	35	32	28	25	22	19	15	12	8	5	2	0
Goodwill	0	0	—	—	—	—	—	—	—	—	—	—
Total assets	1,276	904	704	603	597	738	575	549	532	560	516	504
Accounts payable	148	184	189	177	200	168	170	191	192	180	183	194
Accrued liabilities	63	65	71	77	88	85	92	98	105	111	131	138
Total current liabilities	654	649	596	596	685	959	921	997	1,051	1,248	1,353	1,443
Total liabilities	654	649	596	596	685	959	921	997	1,051	1,248	1,353	1,443
Accumulated deficit	(83,997)	(84,393)	(84,563)	(84,674)	(84,770)	(84,903)	(85,344)	(85,451)	(85,525)	(86,275)	(86,451)	(86,555)
Total stockholders' equity	622	255	107	8	(88)	(221)	(346)	(448)	(519)	(688)	(838)	(939)
Total liabilities and equity	1,276	904	704	603	597	738	575	549	532	560	516	504
Common shares outstanding (cover page) thousands of shares	123,483	123,483	123,483	123,483	125,433	123,483	135,933	135,933	135,933	148,313	148,313	148,313

Fiscal quarters (BUDZ's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	734	(395)	(171)	(111)	(96)	(133)	(440)	(108)	(74)	(750)*	(175)	(104)
Stock-based compensation	—	—	—	—	—	year only	300	0*	—	year only	0	0*
Depreciation and amortization	—	year only	6	11*	0*	6*	6	6*	13*	(2)*	6	5*
Net cash from operating activities	(451)*	(340)*	(178)	(82)*	(20)*	(136)*	(72)	1*	(5)*	(120)*	(58)	(19)*
Purchases of property and equipment	0*	0*	0	0*	0*	—	—	—	—	—	—	—
Net cash from investing activities	1,641*	0*	0	0*	0*	—	—	—	—	—	—	—
Proceeds from issuing common stock	—	year only	—	—	—	—	—	—	—	—	—	—
Net cash from financing activities	(580)*	(15)*	(10)	(5)*	10*	290*	(84)	2*	0*	152*	29	18*
Net change in cash	610*	(355)*	(188)	(87)*	(10)*	154*	(156)	3*	(5)*	—	—	—

SIC 8731 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8731 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Weed	1.1	0	(19)*	148.3M	0.1 quarters	Q2 FY26 10-QJun 30, 2026
Foxo Technologies	58	4,715	299*	1.7M	—	Q2 FY26 10-QJun 30, 2026
iSpecimen	4,414	152	(690)*	2.5M	6.4 quarters	Q2 FY26 10-QJun 30, 2026
Cannabis Bioscience International Holdings	0.1	11	(15)*	11.6B	0.0 quarters	Q3 FY26 10-QFeb 28, 2026
Hypha Labs	5.1	not reported	(52)*	163.9M	0.1 quarters	Q3 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.